Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study

被引：0

作者：

Keitaro Yokoyama

Teruo Hashimoto

Yuri Okuda

Yu Matsumoto

Kyoko Ito

Ryoichi Yamada

Hiroyuki Susai

Noriaki Nishino

机构：

[1] The Jikei University School of Medicine,Department of Health Science, The Graduate School

[2] Pharmaceutical Division,Medical Affairs Department

[3] Japan Tobacco Inc.,Pharmacovigilance Department

[4] Torii Pharmaceutical Co.,undefined

[5] Ltd,undefined

[6] Torii Pharmaceutical Co.,undefined

[7] Ltd,undefined

[8] Harumi Triton Clinic of The Jikei University Hospital Harumi Island Triton Square Office Tower,undefined

来源：

Clinical and Experimental Nephrology | 2022年 / 26卷

关键词：

Ferric citrate; Chronic kidney disease; Hyperphosphatemia; Dialysis; Non-dialysis-dependent; Long-term safety;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：688 / 699

页数：11

共 27 条

[21] Risk factors and their association with mortality in patients undergoing long-term hemodialysis or/and kidney transplant patients or late-stage chronic kidney disease: A single center, prospective observational study
Zhang, Yi
Wu, Minxiang
Mao, Congbo
MEDICINE, 2024, 103 (01) : E36805
[22] Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study
Galle, Jan-Christoph
Addison, Janet
Suranyi, Michael G.
Claes, Kathleen
Di Giulio, Salvatore
Guerin, Alain
Herlitz, Hans
Kiss, Istvan
Farouk, Mourad
Manamley, Nick
Wirnsberger, Gerhard
Winearls, Christopher
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (12) : 2073 - 2085
[23] Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study
Imasawa, Toshiyuki
Saito, Chie
Kai, Hirayasu
Iseki, Kunitoshi
Kazama, Junichiro James
Shibagaki, Yugo
Sugiyama, Hitoshi
Nagata, Daisuke
Narita, Ichiei
Nishino, Tomoya
Hasegawa, Hajime
Honda, Hirokazu
Maruyama, Shoichi
Miyazaki, Mariko
Mukoyama, Masashi
Yasuda, Hideo
Wada, Takashi
Ishikawa, Yuichi
Tsunoda, Ryoya
Nagai, Kei
Okubo, Reiko
Kondo, Masahide
Hoshino, Junichi
Yamagata, Kunihiro
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 158 - 166
[24] Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study
Tsunoda, Ryoya
Usui, Joichi
Hoshino, Junichi
Fujii, Takayuki
Suzuki, Satoshi
Takaichi, Kenmei
Ubara, Yoshifumi
Yamagata, Kunihiro
BMC NEPHROLOGY, 2018, 19
[25] Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study
Ryoya Tsunoda
Joichi Usui
Junichi Hoshino
Takayuki Fujii
Satoshi Suzuki
Kenmei Takaichi
Yoshifumi Ubara
Kunihiro Yamagata
BMC Nephrology, 19
[26] Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study
Roger, Simon D.
Lavin, Philip T.
Lerma, Edgar, V
McCullough, Peter A.
Butler, Javed
Spinowitz, Bruce S.
von Haehling, Stephan
Kosiborod, Mikhail
Zhao, June
Fishbane, Steven
Packham, David K.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (01) : 137 - 150
[27] Long-term effectiveness of a community-based model of care in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) study
Tan, J.
Manley, P.
Gamble, G.
Collins, J.
Bagg, W.
Hotu, C.
Braatvedt, G.
INTERNAL MEDICINE JOURNAL, 2015, 45 (08) : 843 - 849

← 1 2 3 →